Acorah Software Products - Accounts Production 19.4.351 true true false true No description of principal activity 15 January 2025 30 September 2025 30 September 2025 16186939 I A Rawlins D J Clark C N Rawlins iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16186939 2025-01-14 16186939 2025-09-30 16186939 2025-01-15 2025-09-30 16186939 frs-bus:PrivateLimitedCompanyLtd 2025-01-15 2025-09-30 16186939 frs-bus:FilletedAccounts 2025-01-15 2025-09-30 16186939 frs-bus:Micro-entities 2025-01-15 2025-09-30 16186939 frs-bus:EntityHasNeverTraded 2025-01-15 2025-09-30 16186939 frs-bus:AuditExempt-NoAccountantsReport 2025-01-15 2025-09-30 16186939 frs-bus:Director1 2025-01-15 2025-09-30 16186939 frs-bus:Director2 2025-01-15 2025-09-30 16186939 frs-bus:Director3 2025-01-15 2025-09-30
Registered number: 16186939
DXI Regen Limited
Unaudited Financial Statements
For the Period 15 January 2025 to 30 September 2025
Sheppards Chartered Accountants
Suite 2.2 My Buro
20 Market Street
Altrincham
Cheshire
WA14 1PF
Balance Sheet
Registered number: 16186939
30 September 2025
£
Current assets 100
NET CURRENT ASSETS 100
TOTAL ASSETS LESS CURRENT LIABILITIES 100
NET ASSETS 100
CAPITAL AND RESERVES 100

Notes

1. General Information
DXI Regen Limited is a private company, limited by shares, incorporated in England & Wales, registered number 16186939 . The registered office is Suite 2.2 My Buro, 20 Market Street, Altrincham, Cheshire, WA14 1PF.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 30 September 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
I A Rawlins
Director
30th September 2026